计算溶液所需的质量、体积或浓度。
| 活性类型 | 活性值-log(M) | 作用机制 | 期刊 | 参考文献(PubMed IDs) |
|---|
提供 ≥99% 纯度,适用于对基线干扰要求严格的色谱和分析工作流程。
-20°C储存。超低温运输 。请查阅批次 COA 获取详细规格。
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。
MT-DADMe-ImmA is an inhibitor of human 5'-methylthioadenosine phosphorylase ( MTAP ) with a K i of 90 pM.
In Vitro
Treatment of cultured cells with MT-DADMe-ImmA and MTA inhibit MTAP, increase cellular MTA concentrations, decrease polyamines, and induce apoptosis in FaDu and Cal27, two head and neck squamous cell carcinoma cell lines. The same treatment does not induce apoptosis in normal human fibroblast cell lines (CRL2522 and GM02037) or in MCF7, a breast cancer cell line with an MTAP gene deletion. MT-DADMe-ImmA alone does not induce apoptosis in any cell line, implicating MTA as the active agent. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
The t 1/2 for onset of inhibition is 50 min with complete inhibition by 250 min. MTAP activity slowly returns, giving a biological half-life for the action of oral MT-DADMe-ImmA of 6.3 days. The time-dependent growth of FaDu tumors in immunodeficient mice is suppressed by oral or intraperitoneal treatment with MT-DADMe-ImmA. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Cell Assay
Cell viability is evaluated using the Alamar Blue assay. Cells are seeded onto 96-well plates at a density of 104 cells/well and incubated with increasing concentrations of MT-DADMe-ImmA (100 pM to 100 μM) for 4 days at fixed MTA concentrations (0, 5, 10, and 20 μM). IC 50 is determined with the assay data. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Form:Solid
IC50& Target:Ki: 90 pM (MTAP)
分类树(Taxonomy Tree)
| 界(kingdom) | 有机化合物 |
|---|---|
| 超类(Superclass) | 有机杂环化合物 |
| 类(Class) | 吡咯并嘧啶 |
| 亚类(Subclass) | 暂无 |
| 中间层级节点(Intermediate Tree Nodes) | 暂无 |
| 直接上位类(Direct Parent) | 吡咯并嘧啶 |
| 其他上位类(Alternative Parents) | 芳烷基胺 氨基嘧啶及其衍生物 取代吡咯 N-烷基吡咯烷 咪唑内酰胺类 杂芳族化合物 三烷基胺 仲醇 1,2-氨基醇 亚磺酰基化合物 二烷基硫醚 氮杂环化合物 伯胺 有机光子化合物 碳氢化合物衍生物 |
| 分子骨架(Molecular Framework) | 芳香族杂多环化合物 |
| 取代基(Substituents) | 1,2-氨基醇 - 羟基苯甲酸酯 - 氨基酸 - 氨基吡啶 - 芳烷基胺 - 芳香族杂多环化合物 - 氮杂环 - 二烷基硫醚 - 杂芳香族化合物 - 烃衍生物 - 咪唑内酰胺 - N-烷基吡咯烷 - 有机硝基化合物 - 有机氧化合物 - 有机氮化合物 - 有机氧化合物 - 有机氮化合物 - 有机硫化合物 - 初级胺 - 嘧啶 - 吡咯 - 吡咯烷 - 吡咯吡啶 - 醛基 - 取代吡咯 - 硫酰基化合物 - 三元脂肪胺 - 三芳基胺 - 硫醚 |
| 描述(Description) | 该化合物属于吡咯嘧啶类有机化合物。这类化合物含有吡咯嘧啶结构单元,即吡咯环与嘧啶环共轭连接。吡咯为五元环,由四个碳原子和一个氮原子构成;嘧啶为六元环,由四个碳原子及位于1位和3位的两个氮原子中心构成。 |
| 外部描述符(External Descriptors) | 暂无 |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|